Archive - April 2025
Scientists achieve record-breaking growth in miniature, functional liver models
A big moment is coming for psychedelics
Dupixent (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
U.S. Food and Drug Administration Updates Camzyos (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
National Assembly Mulls Expansion of Natural Medicine Agency
New drug delivery method for cell therapies reported
Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer's disease
Commendations as PSN President Commissions NAIP House